CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 260 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP and General Counsel sold 2,715 shares at an average $62.33 ($169,221)
- 4 Grant or award EVP & Chief Commercial Officer acquired 3,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Shares withheld for taxes President & CEO gave up 1,327 shares (to pay taxes)
- 4 Shares withheld for taxes CBO & EVP gave up 346 shares (to pay taxes)
- 4 Shares withheld for taxes Pinion John Richard gave up 260 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Tech Ops Officer gave up 260 shares (to pay taxes)
- 4 Shares withheld for taxes CFO & Executive Vice President gave up 346 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Controller and PAO gave up 433 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Controller and PAO gave up 156 shares (to pay taxes)
Page 17 of 32 · 627 filings